Biohaven (BHVN) | Financial Analysis & Statements

Biohaven Ltd. | Small-cap | Healthcare

$13.79

-5.74%

Biohaven vs Vertex Biohaven vs Regeneron Biohaven vs Vera Therapeutics Biohaven vs Immunocore Holdings Biohaven vs Agios Biohaven vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 0

Operating Income -885.1M

Net Income -846.4M

EPS (Diluted) -$9.28

Balance Sheet Metrics

Total Assets 615.1M

Total Liabilities 191.7M

Shareholders Equity 423.4M

Debt to Equity 0.45

Cash Flow Metrics

Operating Cash Flow -694.1M

Free Cash Flow -586.5M

Revenue & Profitability Trend

Biohaven Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	0	0	0	0	0
Cost of Goods Sold	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expenses	885.1M	436.1M	567.9M	218.9M	114.5M
Operating Income	-885.1M	-436.1M	-567.9M	-218.9M	-114.5M
Pre-tax Income	-845.7M	-409.6M	-569.8M	-212.4M	-118.7M
Income Tax	735.0K	-1.4M	438.0K	1.4M	0
Net Income	-846.4M	-408.2M	-570.3M	-213.8M	-118.7M
EPS (Diluted)	-$9.28	-$5.73	-$12.75	-$5.97	-$3.31

Income Statement Trend

Biohaven Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	538.5M	442.4M	587.0M	94.8M	89.8M
Non-Current Assets	76.6M	70.8M	74.8M	47.2M	21.7M
Total Assets	615.1M	513.2M	661.8M	142.1M	111.5M
Liabilities
Current Liabilities	154.2M	55.4M	90.0M	41.9M	29.9M
Non-Current Liabilities	37.4M	29.8M	33.0M	5.4M	4.8M
Total Liabilities	191.7M	85.2M	123.0M	47.4M	34.7M
Equity
Total Shareholders Equity	423.4M	428.0M	538.8M	94.7M	76.8M

Balance Sheet Composition

Biohaven Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-846.4M	-408.2M	-570.3M	-213.8M	-118.7M
Operating Cash Flow	-694.1M	-351.5M	-273.2M	-139.4M	-92.6M
Investing Activities
Capital Expenditures	-4.0M	-3.0M	-6.1M	-938.0K	-2.7M
Investing Cash Flow	-245.4M	129.8M	-269.8M	944.0K	-2.7M
Financing Activities
Dividends Paid	-	-	-	-	-
Financing Cash Flow	666.3M	211.9M	767.6M	138.4M	152.2M
Free Cash Flow	-586.5M	-334.8M	-338.8M	-146.8M	-78.7M

Cash Flow Trend

Biohaven Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -1.56

Forward P/E -2.29

Price to Book 5.69

PEG Ratio -2.29

Profitability Ratios

Profit Margin 0.00%

Operating Margin 0.00%

Return on Equity -316.82%

Return on Assets -129.99%

Financial Health

Current Ratio 2.33

Debt to Equity 13.69

Beta 3.64

Per Share Data

EPS (TTM) -$9.25

Book Value per Share $2.54

Revenue per Share $0.00

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
bhvn	1.5B	-1.56	5.69	-316.82%	0.00%	13.69
Vertex	114.1B	32.82	6.92	-5.64%	-8.91%	10.00
Regeneron	55.3B	13.02	1.84	15.96%	31.94%	9.20
Vera Therapeutics	1.4B	-8.41	2.58	-39.49%	0.00%	10.18
Immunocore Holdings	1.6B	-31.41	4.13	-5.86%	-6.48%	114.67
Agios	1.9B	2.89	1.32	60.26%	1,798.26%	3.61

Financial data is updated regularly. All figures are in the company's reporting currency.